Anthony S. Gibney, Director at Clearside Biomedical, Inc. (CLSD), bought 100,000 shares at $1.30 ($130K) on 2024-04-18, disclosed to the SEC on 2024-04-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.25 | 6,710 | $8K | 6.5% |
| 2 | $1.30 | 93,290 | $121K | 93.5% |
| Total | $1.30 avg | 100,000 | $130K | 100% |
| Filing → |
| AURA | SELL | 2025-05-20 | $8K | — | Filing → |
| ISEE | SELL | 2022-07-05 | $147K | — | Filing → |